WILMS TUMOR PROTEIN MARKET ANALYSIS

Wilms Tumor Protein Market, By Product Type (Antibodies, Assay Kits, Recombinant Proteins, and Others), By Application (Cancer Diagnosis, Cancer Treatment, Research and Development, and Others), By End User (Hospitals, Diagnostic Laboratories, Research Institutes, and Others), By Detection Method (Immunohistochemistry (IHC), Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting, Polymerase Chain Reaction (PCR), and Others), By Disease Stage (Diagnosis, and Monitoring and Prognosis), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Nov 2023
Code : CMI5825
Pages :160
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Companies covered:

Abcam plc, Thermo Fisher Scientific, Inc., Santa Cruz Biotechnology, Inc., Novus Biologicals, LLC, R&D Systems, Inc. (a subsidiary of Bio-Techne Corporation), OriGene Technologies, Inc., Cell Signaling Technology, Inc., Merck KGaA, BioLegend, Inc., Genetex, Inc. (a subsidiary of Novus Biologicals, LLC), Agilent Technologies, Inc., Proteintech Group, Inc., Sino Biological Inc., Boster Biological Technology, Fitzgerald Industries International

Top companies in Global Wilms Tumor Protein Market